Mount Sinai is recognized for its program in gastrointestinal and digestive medicine. Patients come from across the country to benefit from this program, which aligns innovative procedures, leading-edge technology, and pioneering research to offer outstanding care.

A renowned physician, surgeon, researcher and teacher, Dr. Robin McLeod is dedicated to improving treatment outcomes for patients with colorectal cancer, ulcerative colitis, and Crohn’s disease. She is establishing the highest standard of clinical practice to enhance the treatment of patients affected by gastrointestinal disorders.

“We are internationally known for our work in Crohn’s, Irritable Bowel Syndrome and reconstructive surgery but also for our familial gastrointestinal oncology program, which tracks and treats hereditary colon cancer,” says Dr. McLeod.

Technology has a major role in improving the care that Dr. McLeod and her team can provide. For instance, they recently acquired an argon plasma coagulator, a machine that allows physicians to treat bleeding lesions in the intestinal tract and safely and completely deal with difficult-to-remove polyps. Further, doctors are now using a new type of light source processing – narrow-band imaging – to help detect pre-cancerous lesions and differentiate cancer cells from normal cells.

Dr. McLeod is part of the team at the Dr. Zane Cohen Digestive Diseases Clinical Research Centre and the Samuel Lunenfeld Research Institute. Fellows from all over the world come to Mount Sinai to study with this group. “It really is at the forefront of both medical and surgical treatment.”